Citations (199)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Hui Liu, Ping Li, Aiqi Zhao, Wen Lei, Aibin Liang & Wenbin Qian. (2022) Incidence and prophylaxis of herpes zoster in relapsed or refractory B-cell lymphoma patients after CD19-specific CAR-T cell therapy. Leukemia & Lymphoma 63:4, pages 1001-1004.
Read now
Read now
Olga Zajac-Spychala, Jacek Wachowiak, Anna Szmydki-Baran, Lukasz Hutnik, Malgorzata Salamonowicz, Michal Matysiak, Krzysztof Czyzewski, Mariusz Wysocki, Patrycja Zalas-Wiecek, Zofia Malas, Wanda Badowska, Olga Gryniewicz-Kwiatkowska, Aneta Czajnska-Deptuła, Elwira Kulicka, Bozenna Dembowska-Baginska, Danuta Perek, Katarzyna Semczuk, Katarzyna Dzierzanowska-Fangrat, Tomasz Ociepa, Magdalena Bartnik, Liliana Chelmecka-Wiktorczyk, Walentyna Balwierz, Joanna Klepacka, Nina Irga-Jaworska, Ewa Bien, Elzbieta Adamkiewicz-Drozynska, Agnieszka Urbanek-Dadela, Grazyna Karolczyk, Filip Pierlejewski, Wojciech Mlynarski, Marcin Plonowski, Maryna Krawczuk-Rybak, Weronika Stolpa, Grazyna Sobol, Renata Tomaszewska, Tomasz Szczepanski, Zuzanna Gamrot, Mariola Woszczyk, Maria Wieczorek, Jerzy Kowalczyk & Jan Styczynski. (2019) Infectious complications in children treated for hodgkin and non-hodgkin lymphomas in polish pediatric leukemia/lymphoma study group: incidence, epidemiology and etiology. Leukemia & Lymphoma 60:1, pages 124-132.
Read now
Read now
Saeko Kuwahara-Ota, Yoshiaki Chinen, Yoshimi Mizuno, Tomoko Takimoto-Shimomura, Yayoi Matsumura-Kimoto, Kazuna Tanba, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Tsutomu Kobayashi, Shigeo Horiike & Junya Kuroda. (2018) Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab. Infection and Drug Resistance 11, pages 701-705.
Read now
Read now
Ivan Noreña, Mario Fernández-Ruiz & José María Aguado. (2018) Viral infections in the biologic therapy era. Expert Review of Anti-infective Therapy 16:10, pages 781-791.
Read now
Read now
Tamar Tadmor, Manfred Welslau & Iwona Hus. (2018) A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia. Expert Review of Hematology 11:1, pages 57-70.
Read now
Read now
Hideaki Tsuji, Hajime Yoshifuji, Takao Fujii, Takashi Matsuo, Ran Nakashima, Yoshitaka Imura, Naoichiro Yukawa, Koichiro Ohmura, Shinji Sumiyoshi & Tsuneyo Mimori. (2017) Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis. Modern Rheumatology 27:1, pages 155-161.
Read now
Read now
Sarah Schuler, Matthias Brunner & Wolfgang Bernauer. (2016) Rituximab and Acute Retinal Necrosis in a Patient with Scleromalacia and Rheumatoid Arthritis. Ocular Immunology and Inflammation 24:1, pages 96-98.
Read now
Read now
Qingling Hua, Yanzhe Zhu & Hu Liu. (2015) Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin’s lymphoma (B-NHL) chemotherapy: a meta-analysis. Journal of Chemotherapy 27:6, pages 365-370.
Read now
Read now
Anil Kumar Asthana & John Samuel Lubel. (2014) Reactivation of latent viruses after treatment with biological therapies. Virus Adaptation and Treatment 6, pages 1-10.
Read now
Read now
Peter Riedell & Kenneth R Carson. (2014) A drug safety evaluation of rituximab and risk of hepatitis B. Expert Opinion on Drug Safety 13:7, pages 977-987.
Read now
Read now
Mauro Viganò, Giampaolo Mangia & Pietro Lampertico. (2014) Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy. Expert Opinion on Biological Therapy 14:7, pages 1019-1031.
Read now
Read now
Van Phi Luu, Monica I. Vazquez & Albert Zlotnik. (2014) B cells participate in tolerance and autoimmunity through cytokine production. Autoimmunity 47:1, pages 1-12.
Read now
Read now
Riikka Räty, Tuomo Honkanen, Esa Jantunen, Sirkku Jyrkkiö, Marja-Liisa Karjalainen-Lindsberg, Outi Kuittinen, Minna Lehto, Maija Mikkola, Eira Poikonen, Auvo Rauhala, Johanna Rimpiläinen, Anu Räsänen, Sanna Siitonen, Merja Suominen, Mirja Vapaatalo & Erkki Elonen. (2012) Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group. Leukemia & Lymphoma 53:10, pages 1920-1928.
Read now
Read now
Chadi Nabhan, Sonali M. Smith & Brad S. Kahl. (2012) Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversies. Leukemia & Lymphoma 53:5, pages 770-778.
Read now
Read now
Robert P Baughman & Hilario Nunes. (2012) Therapy for sarcoidosis: evidence-based recommendations. Expert Review of Clinical Immunology 8:1, pages 95-103.
Read now
Read now
Samuel E Moses, ZiYi Lim & Mark A Zuckerman. (2011) Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients. Expert Review of Anti-infective Therapy 9:10, pages 891-899.
Read now
Read now
Florence Uettwiller, Emilie Rigal & Cyrille Hoarau. (2011) Infections associated with monoclonal antibody and fusion protein therapy in humans. mAbs 3:5, pages 461-466.
Read now
Read now
Ramazan Idilman & Mutlu Arat. (2011) Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation. Expert Review of Anti-infective Therapy 9:8, pages 641-652.
Read now
Read now
Joseph Kahwaji, Chris Tong, Stanley C Jordan & Ashley A Vo. (2009) Rituximab: An emerging therapeutic agent for kidney transplantation. Transplant Research and Risk Management 1, pages 15-29.
Read now
Read now
Ron Ram, Isaac Ben-Bassat, Ofer Shpilberg, Aaron Polliack & Pia Raanani. (2009) The late adverse events of rituximab therapy – rare but there!. Leukemia & Lymphoma 50:7, pages 1083-1095.
Read now
Read now
Sercan Aksoy, Ömer Dizdar, Mutlu Hayran & Hakan Harputluoğlu. (2009) Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. Leukemia & Lymphoma 50:3, pages 357-365.
Read now
Read now
Anjum S. Kaka, Cliona M. Rooney & Barbara Savoldo. (2007) What influence has B-cell depletion on viral infections?. Leukemia & Lymphoma 48:7, pages 1257-1258.
Read now
Read now
Articles from other publishers (177)
Thomas Welte, Lukas Westermann, Julia Kappes, Markus A. Schramm, Xavier Bemtgen, Dawid L. Staudacher, Martin J. Hug, Nils Venhoff & Frederic Arnold. (2023)
Identification of Covariates Modulating
B‐Cell
Repopulation Kinetics in Subjects Receiving Rituximab Treatment
. Arthritis & Rheumatology 75:11, pages 2045-2053.
Crossref
Crossref
Xia Pan, Cheng Fang & Yan Chen. (2023) Clinical features of Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: based on an injection nanocarbon tracer labeling method. Soft Computing.
Crossref
Crossref
Julie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, Marie-Sara Agier, Julien Bermudez, Philippe Bonniaud, Raphael Borie, Pierre-Yves Brillet, Jacques Cadranel, Isabelle Court-Fortune, Bruno Crestani, Marie-Pierre Debray, Emmanuel Gomez, Anne Gondouin, Sandrine Hirschi-Santelmo, Dominique Israel-Biet, Stéphane Jouneau, Karine Juvin, Julie Leger, Mallorie Kerjouan, Charles-Hugo Marquette, Jean-Marc Naccache, Hilario Nunes, Laurent Plantier, Grégoire Prevot, Sébastien Quetant, Julie Traclet, Victor Valentin, Yurdagul Uzunhan, Lidwine Wémeau-Stervinou, Theodora Bejan-Angoulvant, Vincent Cottin & Sylvain Marchand-Adam. (2023) Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial. European Respiratory Journal 61:6, pages 2202071.
Crossref
Crossref
Tejas S. Athni & Sara Barmettler. (2023) Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab. Annals of Allergy, Asthma & Immunology 130:6, pages 699-712.
Crossref
Crossref
Mihaela Andreescu. (2023) Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies. Life 13:6, pages 1272.
Crossref
Crossref
Ronak K Kapadia, J Erin Staples, Christine M Gill, Marc Fischer, Ezza Khan, Janeen J Laven, Amanda Panella, Jason O Velez, Holly R Hughes, Aaron Brault, Daniel M Pastula & Carolyn V Gould. (2023) Severe Arboviral Neuroinvasive Disease in Patients on Rituximab Therapy: A Review. Clinical Infectious Diseases 76:6, pages 1142-1148.
Crossref
Crossref
Kathrine E. Attfield, Lise Torp Jensen, Max Kaufmann, Manuel A. Friese & Lars Fugger. (2022) The immunology of multiple sclerosis. Nature Reviews Immunology 22:12, pages 734-750.
Crossref
Crossref
Abdelmohaymin A Abdalla, Joseph Fanciullo & Huthayfa Ateeli. (2022) Delayed Diagnosis of West Nile Meningoencephalitis in a Patient Receiving Rituximab for Rheumatoid Arthritis. Cureus.
Crossref
Crossref
Grzegorz B. Gmyrek, Amanda N. Berube, Virginie H. Sjoelund & Daniel J. J. Carr. (2022) HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition. Scientific Reports 12:1.
Crossref
Crossref
Yuliya Lytvyn, Shahmina Rahat, Asfandyar Mufti, Adrian Witol, Ahmed Bagit, Muskaan Sachdeva & Jensen Yeung. (2022) Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review. Journal of the American Academy of Dermatology 87:1, pages 110-120.
Crossref
Crossref
Fuensanta Gavilán Guirao & Julian Torre Cisneros. 2022. Infectious Complications in Biologic and Targeted Therapies. Infectious Complications in Biologic and Targeted Therapies
369
389
.
Zeinab El Boghdadly, Sajed Sarwar & Mark E. Lustberg. (2021) Infectious Challenges with Novel Antibody–Based Therapies. Current Infectious Disease Reports 23:7.
Crossref
Crossref
Kidangazhiathmana AjithkumarSneha JohnyPinky SalimNeelakandhan Asokan. (2021) Rituximab in pemphigus vulgaris - Standard operating procedure. Journal of Skin and Sexually Transmitted Diseases 4, pages 236-239.
Crossref
Crossref
Emad Kandah, Raghunandan Konda, Atefeh Kalantary, Adan Madadha & Arvind Kunadi. (2021) A Novel Case of Cytomegalovirus Pneumonia in an Acquired Thrombotic Thrombocytopenic Purpura Patient Treated With Rituximab. Cureus.
Crossref
Crossref
Effrossyni Gkrania-Klotsas & Dinakantha S Kumararatne. (2021) Serious Infectious Complications After Rituximab Therapy in Patients With Autoimmunity: Is This the Final Word?. Clinical Infectious Diseases 72:5, pages 738-742.
Crossref
Crossref
Akihiro Ohmoto & Shigeo Fuji. (2021) Infection profiles of different chemotherapy regimens and the clinical feasibility of antimicrobial prophylaxis in patients with DLBCL. Blood Reviews 46, pages 100738.
Crossref
Crossref
Sasha A. Živković, Gregory Gruener & Pushpa Narayanaswami. (2021)
Doctor—Should I get the
COVID
‐19 vaccine? Infection and immunization in individuals with neuromuscular disorders
. Muscle & Nerve 63:3, pages 294-303.
Crossref
Crossref
Hee Ryong Lee, Kipyo Kim, Seoung Woo Lee, Joon Ho Song, Jin Ho Lee & Seun Deuk Hwang. (2021) Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation. Medicine 100:10, pages e24853.
Crossref
Crossref
Wen-Wei Lin, Yun-Chi Lu, Chih-Hung Chuang & Tian-Lu Cheng. (2020) Ab locks for improving the selectivity and safety of antibody drugs. Journal of Biomedical Science 27:1.
Crossref
Crossref
Mariantonietta Pisaturo, Lorenzo Onorato, Antonio Russo & Nicola Coppola. (2020) Prevalence of occult HBV infection in Western countries. Journal of Medical Virology 92:12, pages 2917-2929.
Crossref
Crossref
Shuai Wang, Apoorva Jayarangaiah, Mariuxi Malone, Tarek Elrafei, Lewis Steinberg & Abhishek Kumar. (2020) Risk of hepatitis B reactivation and cytomegalovirus related infections with Mogamulizumab: A retrospective study of international pharmacovigilance database. EClinicalMedicine 28, pages 100601.
Crossref
Crossref
Omid Zahedi Niaki, Milan J. Anadkat, Steven T. Chen, Lindy P. Fox, Joanna Harp, Robert G. Micheletti, Vinod E. Nambudiri, Helena B. Pasieka, Michi M. Shinohara, Misha Rosenbach & Joseph F. Merola. (2020) Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists. Journal of the American Academy of Dermatology 83:4, pages 1150-1159.
Crossref
Crossref
Milad Yazdani, Michael Antonucci & Maria Vittoria Spampinato. (2020) Brain Lesion in the Setting of Chronic Rituximab Treatment. JAMA Oncology 6:7, pages 1093.
Crossref
Crossref
Facundo Fiocca Vernengo, Cristian G. Beccaria, Cintia L. Araujo Furlan, Jimena Tosello Boari, Laura Almada, Melisa Gorosito Serrán, Yamila Gazzoni, Carolina L. Montes, Eva V. Acosta Rodríguez & Adriana Gruppi. (2020)
CD8
+
T Cell Immunity Is Compromised by Anti-CD20 Treatment and Rescued by Interleukin-17A
. mBio 11:3.
Crossref
Crossref
Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye & Michael Boyle. (2020) Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clinical Microbiology Reviews 33:3.
Crossref
Crossref
Dora Y. Ho, Kyle Enriquez & Ashrit Multani. (2020) Herpesvirus Infections Potentiated by Biologics. Infectious Disease Clinics of North America 34:2, pages 311-339.
Crossref
Crossref
Thomas Kiefer, Dorothea Krahl, Thomas Kohlmann, Axel Nogai, Herrad Baurmann, Frank Schüler, William Krüger, Maike Wit, Daniel Pink, Marion Dietz, Heinz Völler, Hermann Buhlert & Georg Daeschlein. (2020) Does rehabilitation pose a risk to patients suffering from haemato‐oncological diseases? Results of a monocentric, retrospective analysis in Germany. European Journal of Cancer Care 29:2.
Crossref
Crossref
Manasi M. Godbole & Paul M. Barr. (2020) Complete recovery of late onset progressive multifocal leukoencephalopathy related to treatment with chemoimmunotherapy: A case report. Leukemia Research 90, pages 106309.
Crossref
Crossref
Ranjit Nair & Krina Patel. 2020. Oncologic Critical Care. Oncologic Critical Care
1499
1512
.
Richard Sullivan, Catriona Gaskell, Craig R. Lewis, Ute Vollmer‐Conna & Jeffrey J. Post. (2019) Infectious disease screening in patients prior to undergoing immunosuppressive therapy. International Journal of Clinical Practice 73:10.
Crossref
Crossref
Mauricio F. FarezJorge CorrealeMelissa J. ArmstrongAlexander Rae-GrantDavid GlossDiane DonleyYolanda Holler-ManaganNorman J. KachuckDouglas JefferyMaureen BeilmanGary GronsethDavid MichelsonErin LeeJulie CoxTom GetchiusJames SejvarPushpa Narayanaswami. (2019) Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis. Neurology 93:13, pages 584-594.
Crossref
Crossref
Yuhong Shi, Yanbin Wu, Yafei Ren, Yanan Jiang & Yiqiang Chen. (2019) Infection risks of rituximab versus non‐rituximab treatment for rheumatoid arthritis: A systematic review and meta‐analysis. International Journal of Rheumatic Diseases 22:8, pages 1361-1370.
Crossref
Crossref
Takatoshi Aoki, Tomohiko Kamimura, Shuro Yoshida, Yasuo Mori, Masanori Kadowaki, Kentaro Kohno, Daisuke Ishihara, Shingo Urata, Takeshi Sugio, Kenjiro Kamezaki, Koji Kato, Yoshikiyo Ito, Tetsuya Eto, Koichi Akashi & Toshihiro Miyamoto. (2019) Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 25:8, pages 1576-1585.
Crossref
Crossref
Denise Yeo, Ihtimam Hossain, Soon Thye Lim, Mohamad Farid, Miriam Tao, Richard Quek, Tiffany Tang & Alexandre Chan. (2018) Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational study. Journal of Oncology Pharmacy Practice 25:5, pages 1042-1052.
Crossref
Crossref
Chiara Briani, Andrea Visentin, Marta Campagnolo, Alessandro Salvalaggio, Sergio Ferrari, Tiziana Cavallaro, Renzo Manara, Roberto Gasparotti & Francesco Piazza. (2019) Peripheral nervous system involvement in lymphomas. Journal of the Peripheral Nervous System 24:1, pages 5-18.
Crossref
Crossref
Zhenjiang Li, Yinping Dong, Min Fan, Yong Yin, Jian Zhu, Baosheng Li & Wei Huang. (2019) Analysis of Hepatitis B Virus Reactivation After Radiotherapy in Patients With Hepatocellular Carcinoma Using the Lyman NTCP Model. Technology in Cancer Research & Treatment 18, pages 153303381987513.
Crossref
Crossref
Ranjit Nair & Krina Patel. 2019. Oncologic Critical Care. Oncologic Critical Care
1
14
.
Amar Safdar & Donald Armstrong. 2019. Principles and Practice of Transplant Infectious Diseases. Principles and Practice of Transplant Infectious Diseases
611
642
.
W. Bernauer, S. Schuler & L. Borradori. (2018) Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid. Journal of Ophthalmic Inflammation and Infection 8:1.
Crossref
Crossref
Alexander D. Yuen, Jason Y. Liu & Jaime Betancourt. (2018) Neuroinvasive Seronegative West Nile Virus in the Setting of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma. Infectious Diseases in Clinical Practice 26:6, pages e85-e87.
Crossref
Crossref
Kashif Ali, Ali Akbar Sial, Mirza Tasawer Baig, Nida Baig, Saqib Hussain Ansari & Tahir Sultan Shamsi. (2017) Detection of the Incidence of HBV, HCV Infection and Febrile Neutropenia Associated With CHOP With or Without Rituximab in Diffuse Large B-Cell Lymphoma–Treated Patients. Hospital Pharmacy 53:3, pages 194-197.
Crossref
Crossref
Masahiko Yazawa, Hideo Sasaki, Yuko Sakurai, Hiroya Kudo, Ryuto Nakazawa, Tatsuya Chikaraishi & Yugo Shibagaki. (2018)
Early post‐transplant diagnosis of cytomegalovirus esophagitis in an
ABO
‐incompatible kidney transplant recipients: A case report
. Transplant Infectious Disease 20:2.
Crossref
Crossref
J. Ciron, B. Audoin, B. Bourre, D. Brassat, F. Durand-Dubief, D. Laplaud, E. Maillart, C. Papeix, S. Vukusic, H. Zephir, R. Marignier & N. Collongues. (2018) Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders. Revue Neurologique 174:4, pages 255-264.
Crossref
Crossref
F. Marchesi, F. Pimpinelli, F. Ensoli & A. Mengarelli. (2018) Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant. Hematological Oncology 36:2, pages 381-391.
Crossref
Crossref
Mohit Dogra, Priya Bajgai, Ashok Kumar & Aman Sharma. (2018) Progressive outer retinal necrosis after rituximab and cyclophosphamide therapy. Indian Journal of Ophthalmology 66:4, pages 591.
Crossref
Crossref
Jean Klastersky, Bernardo L. Rapoport, Matti Aapro & Ronald Feld. 2018. The MASCC Textbook of Cancer Supportive Care and Survivorship. The MASCC Textbook of Cancer Supportive Care and Survivorship
337
348
.
E. Ghrenassia, E. Mariotte & E. Azoulay. 2018. Annual Update in Intensive Care and Emergency Medicine 2018. Annual Update in Intensive Care and Emergency Medicine 2018
579
596
.
Jack W. Hsu, John W. Hiemenz, John R. Wingard & Helen Leather. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
1079
1127
.
Joachim M. Baehring & Amy M. Chan. 2018. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice
559
569
.
Chandrashekar Bohra, Lubomir Sokol & Samir Dalia. (2017) Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies. Cancer Control 24:4, pages 107327481772990.
Crossref
Crossref
Yue Song, Yibo Wen, Weili Xue, Yanjie Zhang & Mingzhi Zhang. (2017) Effect of rituximab on primary central nervous system lymphoma: a meta-analysis. International Journal of Hematology 106:5, pages 612-621.
Crossref
Crossref
Hwa Young Lee, Chin Kook Rhee, Joon Young Choi, Hea Yon Lee, Jong Wook Lee & Dong Gun Lee. (2017) Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies. Oncotarget 8:24, pages 39736-39745.
Crossref
Crossref
Keiki Nagaharu, Yuka Sugimoto, Yuji Hoshi, Takanori Yamaguchi, Ryugo Ito, Keiji Matsubayashi, Keiki Kawakami & Kohshi Ohishi. (2017) Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels. Transfusion 57:6, pages 1414-1418.
Crossref
Crossref
S Elizabeth Franks, Andrew Getahun, P Mark Hogarth & John C Cambier. (2016) Targeting B cells in treatment of autoimmunity. Current Opinion in Immunology 43, pages 39-45.
Crossref
Crossref
C. Sagnelli, M. Macera, M. Pisaturo, R. Zampino, M. Coppola & E. Sagnelli. (2016) Occult HBV infection in the oncohematological setting. Infection 44:5, pages 575-582.
Crossref
Crossref
Tomoo Osumi, Tetsuya Mori, Naoto Fujita, Akiko M. Saito, Atsuko Nakazawa, Masahito Tsurusawa & Ryoji Kobayashi. (2016) Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatric Blood & Cancer 63:10, pages 1794-1799.
Crossref
Crossref
Mahmud BAGHBANIAN, Mehdi HALVANI, Hassan Salman ROGHANI, Mohammad Hassan LOTFI, Mohammad Frahat YAZDI & Hassan-Ali VAHEDIAN-ARDAKANI. (2016) PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT. Arquivos de Gastroenterologia 53:3, pages 175-179.
Crossref
Crossref
Lesia K. Dropulic & Howard M. Lederman. 2016. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host
1
50
.
Lesia K. Dropulic & Howard M. Lederman. (2016) Overview of Infections in the Immunocompromised Host. Microbiology Spectrum 4:4.
Crossref
Crossref
Ami Schattner. (2016) Lesson of the month 2: Against all odds. Clinical Medicine 16:4, pages 394-395.
Crossref
Crossref
. Experimental and Clinical Transplantation 14:2.
Crossref
Crossref
Manoochehr Makvandi. (2016) Update on occult hepatitis B virus infection. World Journal of Gastroenterology 22:39, pages 8720.
Crossref
Crossref
Yoshimi Ishii, Megumi Itabashi, Ayumi Numata, Wataru Yamamoto, Kenji Motohashi, Maki Hagihara, Kenji Matsumoto & Shin Fujisawa. (2016) Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient. Internal Medicine 55:6, pages 673-675.
Crossref
Crossref
J.E.F. Diernaes, J.S.H. Elsner & C. Vestergaard. (2014) Novel presentation of rituximab‐induced herpes zoster: urinary retention and acute kidney failure. Journal of the European Academy of Dermatology and Venereology 30:1, pages 135-136.
Crossref
Crossref
Paula Cramer, Petra Langerbeins & Michael Hallek. (2016) Combination of Targeted Drugs to Control Chronic Lymphocytic Leukemia. The Cancer Journal 22:1, pages 62-66.
Crossref
Crossref
Sejal Morjaria, Esther Arguello, Ying Taur, Kent Sepkowitz, Vaios Hatzoglou, Ajay Nemade, Marc Rosenblum, Marcela S. Cavalcanti, M. Lia Palomba & Anna Kaltsas. (2015) West Nile Virus Central Nervous System Infection in Patients Treated With Rituximab: Implications for Diagnosis and Prognosis, With a Review of Literature. Open Forum Infectious Diseases 2:4.
Crossref
Crossref
Shih-Feng Cho, Wan-Hsuan Wu, Yi-Hsin Yang, Yi-Chang Liu, Hui-Hua Hsiao & Chao-Sung Chang. (2015) Longitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study. Scientific Reports 5:1.
Crossref
Crossref
Robert P. Baughman & Elyse E. Lower. (2015) Treatment of Sarcoidosis. Clinical Reviews in Allergy & Immunology 49:1, pages 79-92.
Crossref
Crossref
Jennifer Worch, Olga Makarova & Birgit Burkhardt. (2015) Immunreconstitution and Infectious Complications After Rituximab Treatment in Children and Adolescents: What Do We Know and What Can We Learn from Adults?. Cancers 7:1, pages 305-328.
Crossref
Crossref
Talal Hilal. (2015) Fatal Cytomegalovirus Disease after Combination Therapy with Corticosteroids and Rituximab for Granulomatosis with Polyangiitis. Case Reports in Rheumatology 2015, pages 1-5.
Crossref
Crossref
Marina P. Siakantaris, Kimon V. Argyropoulos, Savvas Ioannou, Vasiliki Papadopoulou, George Tzeletas, John Tsonis, Aglaia Dimitrakopoulou, Konstantina G. Yiannopoulou, Gerassimos A. Pangalis & George Vaiopoulos. (2015) Cytomegalovirus Meningoencephalitis After Rituximab Treatment for Primary Central Nervous System Lymphoma. The Neurologist 19:2, pages 35-37.
Crossref
Crossref
Valentina Felli, Alessandra Di Sibio, Monica Anselmi, Antonio Gennarelli, Patrizia Sucapane, Alessandra Splendiani, Alessia Catalucci, Carmine Marini & Massimo Gallucci. (2014) Progressive Multifocal Leukoencephalopathy following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. The Neuroradiology Journal 27:6, pages 657-664.
Crossref
Crossref
P.J. Keith, D.A. Wetter, J.W. Wilson & J.S. Lehman. (2014) Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses. British Journal of Dermatology 171:6, pages 1307-1317.
Crossref
Crossref
Abraham Klepfish, Hananya Vaknine & Ami Schattner. (2014) Never say never: unexpected herpes lymphadenitis. The Lancet 384:9954, pages 1640.
Crossref
Crossref
M. Makatsori, S. Kiani-Alikhan, A. L. Manson, N. Verma, M. Leandro, N. P. Gurugama, H. J. Longhurst, S. Grigoriadou, M. Buckland, E. Kanfer, S. Hanson, M. A. A. Ibrahim, B. Grimbacher, R. Chee & S. L. Seneviratne. (2014) Hypogammaglobulinaemia after rituximab treatment--incidence and outcomes. QJM 107:10, pages 821-828.
Crossref
Crossref
Wei Huang, Wei Zhang, Min Fan, Yanda Lu, Jian Zhang, Hongsheng Li & Baosheng Li. (2014) Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma. Cancer Science 105:6, pages 697-703.
Crossref
Crossref
Soham PuvvadaSandra Kurtin. (2014) Toxicity of targeted therapeutic agents in lymphoma and management: part 1: monoclonal antibodies and radioimmunotherapy. International Journal of Hematologic Oncology 3:1, pages 41-51.
Crossref
Crossref
B. A. Ronan, N. Agrwal, E. J. Carey, G. De Petris, S. Kusne, M. T. Seville, J. E. Blair & H. R. Vikram. (2013) Fulminant hepatitis due to human adenovirus. Infection 42:1, pages 105-111.
Crossref
Crossref
Evangelista Sagnelli. (2014) Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World Journal of Hepatology 6:6, pages 384.
Crossref
Crossref
Michael Wang & Stuart Johnson. 2014. Infectious Complications in Cancer Patients. Infectious Complications in Cancer Patients
237
251
.
Mona Gandhi, Joaquin C. Brieva & Mario E. Lacouture. 2014. Infectious Complications in Cancer Patients. Infectious Complications in Cancer Patients
299
317
.
Yevgeniy Balagula, Mario E. Lacouture & James I. Ito. 2013. Dermatologic Principles and Practice in Oncology. Dermatologic Principles and Practice in Oncology
319
336
.
Jessica P Hwang, Michael J Fisch, Anna S-F Lok, Hong Zhang, John M Vierling & Maria E Suarez-Almazor. (2013) Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer 13:1.
Crossref
Crossref
Simone Lanini, Aoife C Molloy, Archibald G Prentice, Giuseppe Ippolito & Christopher C Kibbler. (2013) Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study. BMC Infectious Diseases 13:1.
Crossref
Crossref
Juan José Alonso, Araceli Cánovas & Gurutze Rubio. (2013) Miocarditis mortal por enterovirus asociada a tratamiento de linfoma folicular con rituximab y quimioterapia. Medicina Clínica 141:10, pages 459-460.
Crossref
Crossref
Paul Shaughnessy & Helen Leather. 2013. Blood and Marrow Transplantation Long‐Term Management. Blood and Marrow Transplantation Long‐Term Management
314
320
.
Irit Avivi, Dina Stroopinsky & Tamar Katz. (2013) Anti-CD20 monoclonal antibodies: Beyond B-cells. Blood Reviews 27:5, pages 217-223.
Crossref
Crossref
DeepakBabu Chellapandian, Rupali Das, Kristin Zelley, Susan J. Wiener, Huaqing Zhao, David T. Teachey & Kim E. Nichols. (2013) Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. British Journal of Haematology 162:3, pages 376-382.
Crossref
Crossref
Hua-Jie Dong, Ling-Na Ni, Gui-Feng Sheng, Hong-Lei Song, Jian-Zhong Xu & Yang Ling. (2013) Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis. Journal of Clinical Virology 57:3, pages 209-214.
Crossref
Crossref
Mario Mandalà, Stefano Fagiuoli, Daniela Francisci, Raffaele Bruno, Barbara Merelli, Luisa Pasulo, Carlo Tondini, Roberto Labianca & Fausto Roila. (2013) Hepatitis B in immunosuppressed cancer patients: Pathogenesis, incidence and prophylaxis. Critical Reviews in Oncology/Hematology 87:1, pages 12-27.
Crossref
Crossref
Marko Kavcic, Brian T. Fisher, Alix E. Seif, Yimei Li, Yuan-Shung Huang, Dana Walker & Richard Aplenc. (2013) Leveraging Administrative Data to Monitor Rituximab Use in 2875 Patients at 42 Freestanding Children's Hospitals across the United States. The Journal of Pediatrics 162:6, pages 1252-1258.e1.
Crossref
Crossref
Jing Lu Kroll, Craig Beam, Shaobing Li, Raphael Viscidi, Bonnie Dighero, Alice Cho, David Boulware, Mark Pescovitz & Adriana Weinberg. (2013) Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes. Journal of Clinical Virology 57:2, pages 115-119.
Crossref
Crossref
B. Casanova Estruch. (2013) Safety profile and practical considerations of monoclonal antibody treatment. Neurología (English Edition) 28:3, pages 169-178.
Crossref
Crossref
B. Casanova Estruch. (2013) Perfil de seguridad y aspectos prácticos a tener en cuenta en la administración de anticuerpos monoclonales. Neurología 28:3, pages 169-178.
Crossref
Crossref
S. Neumann, S. W. Krause, G. Maschmeyer, X. Schiel & M. von Lilienfeld-Toal. (2013) Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors. Annals of Hematology 92:4, pages 433-442.
Crossref
Crossref
Gilda Tonziello, Marintonietta Pisaturo, Antonello Sica, Maria Giovanna Ferrara, Caterina Sagnelli, Giuseppe Pasquale, Evangelista Sagnelli, Salvatore Guastafierro & Nicola Coppola. (2012) Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma. Infection 41:1, pages 225-229.
Crossref
Crossref
CHRISTIAN H. ROUX, RODOLPHE ANTY, STEPHANIE PATOURAUX & LIANA EULLER-ZIEGLER. (2013) Hepatitis E: Are Rheumatic Patients at Risk?. The Journal of Rheumatology 40:1, pages 99-99.
Crossref
Crossref
Myung Jin OhHeon Ju Lee. (2013) A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience. Clinical and Molecular Hepatology 19:1, pages 51.
Crossref
Crossref
Anna L. Hutchinson, Yi Ling Tan & Giselle Kidson-Gerber. (2013) A Case of an Acquired Factor VIII Inhibitor Complicated by Multiple Treatment-Related Opportunistic Infections and Review of the Literature. Case Reports in Hematology 2013, pages 1-4.
Crossref
Crossref
Jack W. Hsu, John W. Hiemenz, John R. Wingard & Helen Leather. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
1193
1239
.
Akinao Okamoto, Akihiro Abe, Masataka Okamoto, Tsukane Kobayashi, Tomohiko Terazawa, Yoko Inaguma, Masutaka Tokuda, Masamitsu Yanada, Satoko Morishima, Tadaharu Kanie, Yukiya Yamamoto, Motohiro Tsuzuki, Yoshiki Akatsuka, Shuichi Mizuta, Tetsushi Yoshikawa & Nobuhiko Emi. (2012) Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy. International Journal of Hematology 96:4, pages 516-520.
Crossref
Crossref
Serena Delbue, Mariano Ferraresso, Francesca Elia, Mirco Belingheri, Camilla Carloni, Lucia Signorini, Silvia Carluccio, Simone Dallari, Luciana Ghio & Pasquale Ferrante. (2012) Investigation of polyomaviruses replication in pediatric patients with nephropathy receiving rituximab. Journal of Medical Virology 84:9, pages 1464-1470.
Crossref
Crossref
Yasuo Mori, Toshihiro Miyamoto, Kenjiro Kamezaki, Koji Kato, Yoshikane Kikushige, Shuichiro Takashima, Shingo Urata, Shinji Shimoda, Nobuyuki Shimono, Katsuto Takenaka, Hiromi Iwasaki, Koji Nagafuji, Takanori Teshima & Koichi Akashi. (2012) Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era. American Journal of Hematology 87:8, pages 828-830.
Crossref
Crossref
M-J Tsai, C-W Chou, F-C Lin & S-C Chang. (2012)
Pneumocystis jiroveci
pneumonia in patients with systemic lupus erythematosus after rituximab therapy
. Lupus 21:8, pages 914-918.
Crossref
Crossref
Michael W. Ferenczy, Leslie J. Marshall, Christian D. S. Nelson, Walter J. Atwood, Avindra Nath, Kamel Khalili & Eugene O. Major. (2012) Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain. Clinical Microbiology Reviews 25:3, pages 471-506.
Crossref
Crossref
Wilma BarcelliniFrancesco ZajaAnna ZaninoniFrancesca Guia ImperialiMarta Lisa BattistaEros Di BonaBruno FattizzoDario Consonni, Agostino Cortelezzi, Renato FaninAlberto Zanella. (2012) Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. Blood 119:16, pages 3691-3697.
Crossref
Crossref
Harrys A. Torres & Marta Davila. (2012) Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nature Reviews Clinical Oncology 9:3, pages 156-166.
Crossref
Crossref
Panagiotis Papamichalis, Alexis Alexiou, Maria Boulbou, George N. Dalekos & Eirini I. Rigopoulou. (2012) Reactivation of resolved hepatitis B virus infection after immunosuppression: Is it time to adopt pre-emptive therapy?. Clinics and Research in Hepatology and Gastroenterology 36:1, pages 84-93.
Crossref
Crossref
Shih-Hung Yang, Long-Wei Lin, Yu-Jen Fang, Ann-Lii Cheng & Sung-Hsin Kuo. (2011) Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma. Annals of Hematology 91:2, pages 291-294.
Crossref
Crossref
Pashtoon M Kasi, Hussein A Tawbi, Chester V Oddis & Hrishikesh S Kulkarni. (2012) Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective. Critical Care 16:4, pages 231.
Crossref
Crossref
Evangelista Sagnelli, Mariantonietta Pisaturo, Caterina Sagnelli & Nicola Coppola. (2012) Rituximab-Based Treatment, HCV Replication, and Hepatic Flares. Clinical and Developmental Immunology 2012, pages 1-5.
Crossref
Crossref
Robert P. Baughman, Ulrich Costabel & Elyse E. Lower. 2012. Diffuse Lung Disease. Diffuse Lung Disease
101
120
.
Joseph Kahwaji, Aditi Sinha, Mieko Toyoda, Shili Ge, Nancy Reinsmoen, Kai Cao, Chih-Hung Lai, Rafael Villicana, Alice Peng, Stanley Jordan & Ashley Vo. (2011) Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin. Clinical Journal of the American Society of Nephrology 6:12, pages 2894-2900.
Crossref
Crossref
Simone Lanini, Aoife C Molloy, Paul E Fine, Archibald G Prentice, Giuseppe Ippolito & Christopher C Kibbler. (2011) Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis. BMC Medicine 9:1.
Crossref
Crossref
G. Gentile & R. Foà. (2011) Viral infections associated with the clinical use of monoclonal antibodies. Clinical Microbiology and Infection 17:12, pages 1769-1775.
Crossref
Crossref
R. Cavallo. (2011) The laboratory of clinical virology in monitoring patients undergoing monoclonal antibody therapy. Clinical Microbiology and Infection 17:12, pages 1781-1785.
Crossref
Crossref
A. Habicht, V. Broker, C. Blume, J. Lorenzen, M. Schiffer, N. Richter, J. Klempnauer, H. Haller, F. Lehner & A. Schwarz. (2011) Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. Nephrology Dialysis Transplantation 26:12, pages 4124-4131.
Crossref
Crossref
Nicola Coppola, Gilda Tonziello, Mariantonietta Pisaturo, Vincenzo Messina, Salvatore Guastafierro, Marco Fiore, Valentina Iodice, Caterina Sagnelli, Maria Stanzione, Nicolina Capoluongo, Giuseppe Pasquale & Evangelista Sagnelli. (2011) Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. Journal of Medical Virology 83:11, pages 1909-1916.
Crossref
Crossref
Yuji Hirai, Yusuke Ainoda, Takayo Shoji, Takahiro Fujita, Kentaro Yoshinaga, Masayuki Shiseki, Naoki Mori, Masanao Teramura, Kyoichi Totsuka & Toshiko Motoji. (2011) Disseminated Cryptococcosis in a Non-Hodgkin’s Lymphoma Patient with Late-Onset Neutropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review. Mycopathologia 172:3, pages 227-232.
Crossref
Crossref
Stephanie Gaillard, Jason B. Dinoso, Julia A. Marsh, Amy E. DeZern, Karen A. O’Connell, Adam M. Spivak, Karla Alwood, Christine M. Durand, Richard F. Ambinder & Joel N. Blankson. (2011) Sustained elite suppression of replication competent HIV-1 in a patient treated with rituximab based chemotherapy. Journal of Clinical Virology 51:3, pages 195-198.
Crossref
Crossref
Bernardo Leon Rapoport. (2011) Management of the Cancer Patient With Infection and Neutropenia. Seminars in Oncology 38:3, pages 424-430.
Crossref
Crossref
Wilma Barcellini & Alberto Zanella. (2011) Rituximab therapy for autoimmune haematological diseases. European Journal of Internal Medicine 22:3, pages 220-229.
Crossref
Crossref
A.M. Evens, B.D. Jovanovic, Y.-C. Su, D.W. Raisch, D. Ganger, S.M. Belknap, M.-S. Dai, B.-C. C. Chiu, B. Fintel, Y. Cheng, S.-S. Chuang, M.-Y. Lee, T.-Y. Chen, S.-F. Lin & C.-Y. Kuo. (2011) Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Annals of Oncology 22:5, pages 1170-1180.
Crossref
Crossref
Shang-Gin Wu, Tzu-Hsiu Tsai & Shang-Ju Wu. (2011) Acute Cytomegalovirus Pneumonitis in Patient with Lymphomatoid Granulomatosis. Emerging Infectious Diseases 17:4, pages 741-742.
Crossref
Crossref
Manuel Ramos-Casals, Cándido Díaz-Lagares & Munther A. Khamashta. (2011) Tratamiento depletivo de células B en enfermedades autoinmunitarias sistémicas. Recomendaciones de uso en la práctica clínica. Medicina Clínica 136:6, pages 257-263.
Crossref
Crossref
Lisa J. Toltl & Donald M. Arnold. (2011) Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. British Journal of Haematology 152:1, pages 52-60.
Crossref
Crossref
Emilio Martín Mola, Blanca Hernández, Miriam García-Arias, José María Álvaro-Gracia, Alejandro Balsa, Juan Gómez Reino, José L. Marenco de la Fuente, Víctor Martínez-Taboada, José Andrés Román Ivorra & Raimon Sanmartí. (2011) Consenso de uso de rituximab en artritis reumatoide. Un documento con recomendaciones basadas en la evidencia. Reumatología Clínica 7:1, pages 30-44.
Crossref
Crossref
Theodoros Kelesidis, George Daikos, Dimitrios Boumpas & Sotirios Tsiodras. (2011) Does rituximab increase the incidence of infectious complications? A narrative review. International Journal of Infectious Diseases 15:1, pages e2-e16.
Crossref
Crossref
Emilio Martín Mola, Blanca Hernández, Miriam García-Arias, José María Álvaro-Gracia, Alejandro Balsa, Juan Gómez-Reino, José L. Marenco de la Fuente, Víctor Martínez-Taboada, José Andrés Román Ivorra & Raimon Sanmartí. (2011) Consensus on the use of Rituximab in Rheumatoid Arthritis. A document with evidence based recommendations. Reumatología Clínica (English Edition) 7:1, pages 30-44.
Crossref
Crossref
Carlo Marinone & Monica Mestriner. (2011) HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting. Digestive and Liver Disease 43, pages S49-S56.
Crossref
Crossref
Hung Chang & Lee-Yung Shih. 2011. Pulmonary Involvement in Patients with Hematological Malignancies. Pulmonary Involvement in Patients with Hematological Malignancies
781
785
.
Yair Herishanu, Chava Perry & Aaron Polliack. 2011. Pulmonary Involvement in Patients with Hematological Malignancies. Pulmonary Involvement in Patients with Hematological Malignancies
751
757
.
André Goy & Susan O’Brien. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases
47
66
.
Marta Davila & Harrys A. Torres. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases
189
194
.
Christopher Joseph Del PreteNeil S. Cohen. (2010) A Case of Rituximab-Induced Hepatitis. Cancer Biotherapy and Radiopharmaceuticals 25:6, pages 747-748.
Crossref
Crossref
M. Behnes, K. Mashayekhi, G. Geginat & M. Borggrefe. (2010) Horse bacterium causes human pericardial and pleural effusion. Infection 38:6, pages 501-504.
Crossref
Crossref
Francisco Javier Peñalver, Alberto Alvarez-Larrán, Jose Luis Díez-Martin, Laura Gallur, Isidro Jarque, Dolores Caballero, Joaquín Díaz-Mediavilla, Rosalía Bustelos, María Jesús Fernández-Aceñero & José Rafael Cabrera. (2010) Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. Annals of Hematology 89:11, pages 1073-1080.
Crossref
Crossref
Kuan-Hsiang G. Huang, David Bonsall, Aris Katzourakis, Emma C. Thomson, Sarah J. Fidler, Janice Main, David Muir, Jonathan N. Weber, Alexander J. Frater, Rodney E. Phillips, Oliver G. Pybus, Philip J.R. Goulder, Myra O. McClure, Graham S. Cooke & Paul Klenerman. (2010) B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nature Communications 1:1.
Crossref
Crossref
Vincent Pestre & Luc Mouthon. (2010) Manifestations pulmonaires associées aux immunosuppresseurs utilisés dans les transplantations et les maladies auto-immunes. La Presse Médicale 39:9, pages 878-886.
Crossref
Crossref
Mehnaz A. Shafi & Robert S. Bresalier. (2010) The Gastrointestinal Complications of Oncologic Therapy. Gastroenterology Clinics of North America 39:3, pages 629-647.
Crossref
Crossref
Angela Rago, Miriam Lichtner, Sergio Mecarocci, Raffaella Marocco, Natalia Cenfra, Valeria Belvisi, Cosmo Del Borgo, Giuseppe Cimino & Claudio M Mastroianni. (2010) Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen. Antiviral Therapy 15:6, pages 929-932.
Crossref
Crossref
Jakob Paues & Magnus Vrethem. (2010) Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab. Journal of Clinical Virology 48:4, pages 291-293.
Crossref
Crossref
Hannah Tamary, Jelena Roganovic, Meera Chitlur & Diane J. Nugent. (2010) Consensus Paper—ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia. Annals of Hematology 89:S1, pages 5-10.
Crossref
Crossref
Luisa Giaccone, Moreno Festuccia, Andrea Marengo, Isabel Resta, Roberto Sorasio, Fabrizia Pittaluga, Francesca Fiore, Mario Boccadoro, Mario Rizzetto, Benedetto Bruno & Alfredo Marzano. (2010) Hepatitis B Virus Reactivation and Efficacy of Prophylaxis with Lamivudine in Patients Undergoing Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 16:6, pages 809-817.
Crossref
Crossref
Agustin Avilés, Natividad Neri, Judith Huerta-Guzmán & María de Jesús Nambo. (2010) ESHAP Versus Rituximab-ESHAP in Frail Patients With Refractory Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 10:2, pages 125-128.
Crossref
Crossref
S. Y. Lim & C. S. Constantinescu. (2010) Current and future disease-modifying therapies in multiple sclerosis. International Journal of Clinical Practice 64:5, pages 637-650.
Crossref
Crossref
Nichola Cooper & Donald M. Arnold. (2010) The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. British Journal of Haematology 149:1, pages 3-13.
Crossref
Crossref
Trevor T. Hansel, Harald Kropshofer, Thomas Singer, Jane A. Mitchell & Andrew J. T. George. (2010) The safety and side effects of monoclonal antibodies. Nature Reviews Drug Discovery 9:4, pages 325-338.
Crossref
Crossref
Susan Lee & Mark Ballow. (2010) Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseases. Journal of Allergy and Clinical Immunology 125:4, pages 814-820.
Crossref
Crossref
DAN-AVI LANDAU, SAMY SCERRA, DAMIEN SENE, MATHIEU RESCHE-RIGON, DAVID SAADOUN & PATRICE CACOUB. (2010) Causes and Predictive Factors of Mortality in a Cohort of Patients with Hepatitis C Virus-related Cryoglobulinemic Vasculitis Treated with Antiviral Therapy. The Journal of Rheumatology 37:3, pages 615-621.
Crossref
Crossref
I-Cheng Lee, Yi-Hsiang Huang, Chi-Jen Chu, Pui-Ching Lee, Han-Chieh Lin & Shou-Dong Lee. (2010) Hepatitis B Virus Reactivation After 23 Months of Rituximab-based Chemotherapy in an HBsAg-negative, Anti-HBs-positive Patient With Follicular Lymphoma. Journal of the Chinese Medical Association 73:3, pages 156-160.
Crossref
Crossref
N. Kamar, O. Milioto, B. Puissant‐Lubrano, L. Esposito, M.C. Pierre, A.Ould Mohamed, L. Lavayssière, O. Cointault, D. Ribes, I. Cardeau, M.B. Nogier, D. Durand, M. Abbal, A. Blancher & L. Rostaing. (2010) Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney‐Transplant Patients. American Journal of Transplantation 10:1, pages 89-98.
Crossref
Crossref
Bernardo L. Rapoport & Ronald Feld. 2011. The MASCC Textbook of Cancer Supportive Care and Survivorship. The MASCC Textbook of Cancer Supportive Care and Survivorship
195
202
.
Émilie Rigal, Philippe Gateault, Yvon Lebranchu & Cyrille Hoarau. (2009) Les complications infectieuses liées à l’utilisation des anticorps monoclonaux chez l’homme. médecine/sciences 25:12, pages 1135-1140.
Crossref
Crossref
Mischelle A. Elliott, John A. Heit, Rajiv K. Pruthi, Dennis A. Gastineau, Jeffrey L. Winters & C. Christopher Hook. (2009) Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature. European Journal of Haematology 83:4, pages 365-372.
Crossref
Crossref
EDWARD SHELTON, MICHELLE YONG & SOLOMON COHNEY. (2009) Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection. Nephrology 14:7, pages 696-699.
Crossref
Crossref
Hayato Nishida, Hideki Ishida, Toshiaki Tanaka, Hiroyuki Amano, Kazuya Omoto, Hiroki Shirakawa, Tomokazu Shimizu, Shoichi Iida, Daisuke Toki, Yutaka Yamaguchi & Kazunari Tanabe. (2009) Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy. Transplant International 22:10, pages 961-969.
Crossref
Crossref
. (2009) References. Bone Marrow Transplantation 44:8, pages 537-557.
Crossref
Crossref
Marcie Tomblyn, Tom Chiller, Hermann Einsele, Ronald Gress, Kent Sepkowitz, Jan Storek, John R. Wingard, Jo-Anne H. Young & Michael A. Boeckh. (2009) Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective. Biology of Blood and Marrow Transplantation 15:10, pages 1143-1238.
Crossref
Crossref
Manish Sharma, Jocelyn Moore, Vu Nguyen & Koen Van Besien. (2009) Fatal CMV pneumonitis in a lymphoma patient treated with rituximab. American Journal of Hematology 84:9, pages 614-616.
Crossref
Crossref
WENDLING DANIEL, VINCENT DI MARTINO & GEORGES HERBEIN. (2009) Biologic Agents in the Treatment of Rheumatic Diseases with Chronic Viral Infection. Where Are We?. The Journal of Rheumatology 36:6, pages 1107-1108.
Crossref
Crossref
Kenneth R. CarsonAndrew M. EvensElizabeth A. RicheyThomas M. HabermannDaniele FocosiJohn F. SeymourJacob LaubachSusie D. BawnLeo I. GordonJane N. WinterRichard R. FurmanJulie M. VoseAndrew D. ZelenetzRonac MamtaniDennis W. RaischGary W. DorshimerSteven T. RosenKenji Muro, Numa R. Gottardi-LittellRobert L. TalleyOliver SartorDavid GreenEugene O. Major & Charles L. Bennett. (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113:20, pages 4834-4840.
Crossref
Crossref
Raymond Liang. (2009) How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood 113:14, pages 3147-3153.
Crossref
Crossref
G. Maschmeyer & M. Sandherr. (2009) Infektionen in der Hämatologie und OnkologieInfections in hematology and oncology. Der Internist 50:2, pages 187-202.
Crossref
Crossref
Yuko Kanbayashi, Kenichi Nomura, Yoshiko Fujimoto, Mihoko Yamashita, Muneo Ohshiro, Kousuke Okamoto, Yosuke Matsumoto, Shigeo Horiike, Tatsuya Takagi, Yoji Ishida & Masafumi Taniwaki. (2009) Risk factors for infection in haematology patients treated with rituximab. European Journal of Haematology 82:1, pages 26-30.
Crossref
Crossref
Anna Johnston, Gilles Salles, Daniel Espinouse, Pascale Felman, Patrice André, Françoise Berger & Bertrand Coiffier. (2008) Epstein-Barr Virus—Induced Lymphoproliferative Disorder After Rituximab Combined with CHOP Therapy. Clinical Lymphoma and Myeloma 8:6, pages 356-358.
Crossref
Crossref
Marta Davila & Robert S Bresalier. (2008) Gastrointestinal complications of oncologic therapy. Nature Clinical Practice Gastroenterology & Hepatology 5:12, pages 682-696.
Crossref
Crossref
Lesia K. Dropulic & Howard M. Lederman. 2008. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host
1
43
.
Alexandra M Levine. (2008) Management of AIDS-related lymphoma. Current Opinion in Oncology 20:5, pages 522-528.
Crossref
Crossref
Omer Dizdar, Umit Tapan, Sercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap & Ibrahim Barista. (2008) Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C. European Journal of Haematology 80:5, pages 381-385.
Crossref
Crossref
L. L. Teichmann, M. Woenckhaus, C. Vogel, B. Salzberger, J. Scholmerich & M. Fleck. (2008) Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. Rheumatology 47:8, pages 1256-1257.
Crossref
Crossref
Bernadette Garvey. (2008) Rituximab in the treatment of autoimmune haematological disorders. British Journal of Haematology 141:2, pages 149-169.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:3.
Crossref
Crossref
Adrian Newland. (2008) Emerging strategies to treat chronic immune thrombocytopenic purpura. European Journal of Haematology 80, pages 27-33.
Crossref
Crossref
Francesco Rodeghiero. (2008) First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. European Journal of Haematology 80, pages 19-26.
Crossref
Crossref
Ayodele Ayoola, Wajahath Mohsini & Sein Aung. (2008) Acquired Factor VIII Inhibitor in a Patient with Dermatomyositis – A Case Study. Acta Haematologica 119:1, pages 8-11.
Crossref
Crossref
R. Bergamaschi. (2007) Immune agents for the treatment of Devic’s neuromyelitis optica. Neurological Sciences 28:5, pages 238-240.
Crossref
Crossref